Chun-Xi Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chun-Xi Wang has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Chang ZhenYu
Department of General Surgery, The First Medical Center of Chinese, PLA General Hospital, Beijing, China
3 shared publicationsZhu MingHua
Department of General Surgery, The First Medical Center of Chinese, PLA General Hospital, Beijing, China
3 shared publicationsMing-Hua Zhu
Department of General surgery, Chinese People's Liberation Army General Hospital, Beijing, China
2 shared publicationsZe-Long Yang
Department of General surgery, Chinese People's Liberation Army General Hospital, Beijing, China
2 shared publicationsChen JingRu
Department of General Surgery, The First Medical Center of Chinese, PLA General Hospital, Beijing, China
1 shared publicationChen Lin
Department of General Surgery, Chinese People’s Liberation Army General Hospital, Beijing, China
1 shared publication
Latest Publications
- 10 June 2024
- Published by Springer Nature in Surgical Endoscopy
- Vol. 38 (8) , 4215-4221
Comparable long-term survival outcomes after endoscopic and gastrectomy treatment of pT1acN0M0 gastric adenocarcinoma in patients who met the expanded criteria
Background Whether the Western pT1acN0M0 gastric cancer (GC) patients who met the Japanese expanded criteria could be the candidates for endoscopic treatment (ET) remains unclear because of unknown long-term survival outcomes. Methods A retrospective cohort study using data from the Surveillance, Epidemiology, and End Results (SEER) program was performed. The survival differences between pT1acN0M0 gastric adenocarcinoma patients who received ET or gastrectomy treatment (GT) were evaluated using multivariate survival analysis. Results A total of 314 pT1acN0M0 gastric adenocarcinoma patients who met the expanded criteria were included, 46 patients received ET and 268 patients received GT. pT1acN0M0 gastric adenocarcinoma patients met the expanded criteria underwent ET experienced a similar hazard of cancer-specific death compared with those underwent GT both in the multivariate Cox survival analysis (adjusted hazard ratio [HR]; 1.18, 95% confidence interval [CI] 0.40–3.49; P = 0.766) and the multivariate competing risk model (subdistribution HR [SHR], 1.12, 95% CI 0.38–3.29; P = 0.845). The result that pT1acN0M0 gastric adenocarcinoma patients met the expanded criteria underwent ET experienced comparable survival outcomes to those who underwent GT did not change even compared with those who underwent GT with > 15 lymph nodes examined (adjusted HR, 1.55, 95% CI 0.44–5.49; P = 0.499; SHR, 1.47, 95% CI 0.44–4.88; P = 0.532). Conclusions The ET can be considered in Western pT1acN0M0 gastric adenocarcinoma patients who met the Japanese expanded criteria. However, a prospective study should be warranted.
- 10 June 2024
- Published by Springer Nature in Surgical Endoscopy
- Vol. 38 (8) , 4215-4221
Comparable long-term survival outcomes after endoscopic and gastrectomy treatment of pT1acN0M0 gastric adenocarcinoma in patients who met the expanded criteria
Background Whether the Western pT1acN0M0 gastric cancer (GC) patients who met the Japanese expanded criteria could be the candidates for endoscopic treatment (ET) remains unclear because of unknown long-term survival outcomes. Methods A retrospective cohort study using data from the Surveillance, Epidemiology, and End Results (SEER) program was performed. The survival differences between pT1acN0M0 gastric adenocarcinoma patients who received ET or gastrectomy treatment (GT) were evaluated using multivariate survival analysis. Results A total of 314 pT1acN0M0 gastric adenocarcinoma patients who met the expanded criteria were included, 46 patients received ET and 268 patients received GT. pT1acN0M0 gastric adenocarcinoma patients met the expanded criteria underwent ET experienced a similar hazard of cancer-specific death compared with those underwent GT both in the multivariate Cox survival analysis (adjusted hazard ratio [HR]; 1.18, 95% confidence interval [CI] 0.40–3.49; P = 0.766) and the multivariate competing risk model (subdistribution HR [SHR], 1.12, 95% CI 0.38–3.29; P = 0.845). The result that pT1acN0M0 gastric adenocarcinoma patients met the expanded criteria underwent ET experienced comparable survival outcomes to those who underwent GT did not change even compared with those who underwent GT with > 15 lymph nodes examined (adjusted HR, 1.55, 95% CI 0.44–5.49; P = 0.499; SHR, 1.47, 95% CI 0.44–4.88; P = 0.532). Conclusions The ET can be considered in Western pT1acN0M0 gastric adenocarcinoma patients who met the Japanese expanded criteria. However, a prospective study should be warranted.
- 21 April 2020
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 25 (4) , 919-925
Impact of Lymph Nodes Examined on Survival in ypN0 Gastric Cancer Patients: a Population-Based Study
- 21 April 2020
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 25 (4) , 919-925
Impact of Lymph Nodes Examined on Survival in ypN0 Gastric Cancer Patients: a Population-Based Study
- 28 August 2019
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 24 (9) , 1978-1986
Influence of Tumor Location on Lymph Node Metastasis and Survival for Early Gastric Cancer: a Population-Based Study
- 28 August 2019
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 24 (9) , 1978-1986
Influence of Tumor Location on Lymph Node Metastasis and Survival for Early Gastric Cancer: a Population-Based Study
- Open Access
- 3 May 2019
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 9, 329
Modified American Joint Committee on Cancer Tumor-Node-Metastasis Staging System Based on the Node Ratio Can Further Improve the Capacity of Prognosis Assessment for Gastric Cancer Patients
Background and Objectives: Our aim was to investigate whether the modified American Joint Committee on Cancer (AJCC) tumor-node-metastasis (TNM) staging system based on the node ratio can further improve the capacity of prognosis assessment for gastric cancer (GC) patients regardless of the number of lymph nodes examined (eLNs). Methods: A total of 17,187 GC patients in the Surveillance, Epidemiology, and End Results (SEER) database were included. On the basis of a training set of 7,660 GC patients, we built the tumor-node ratio-metastasis (TNrM) staging system, which was then externally validated with a validation set of 9,527 GC patients. Results: For the training set, the C-index value of the TNrM staging system was significantly higher than that of the AJCC 8th TNM staging system to predict survival for GC patients (C-index: 0.688 vs. 0.671, P < 0.001). Moreover, the C-index value of the TNrM staging system was significantly higher than that of the 8th TNM staging system to predict survival for GC patients with ≤15 eLNs (C-index: 0.682 vs. 0.673, P < 0.001), as well as for GC patients with >15 eLNs (C-index: 0.700 vs. 0.694, P < 0.001). Similar results were found in the validation set. Conclusions: The TNrM staging system predicted survival more accurately and discriminatively than the AJCC 8th TNM staging system for GC patients regardless of the number of eLNs.
- 3 May 2019
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 9, 329
Open AccessModified American Joint Committee on Cancer Tumor-Node-Metastasis Staging System Based on the Node Ratio Can Further Improve the Capacity of Prognosis Assessment for Gastric Cancer Patients
Background and Objectives: Our aim was to investigate whether the modified American Joint Committee on Cancer (AJCC) tumor-node-metastasis (TNM) staging system based on the node ratio can further improve the capacity of prognosis assessment for gastric cancer (GC) patients regardless of the number of lymph nodes examined (eLNs). Methods: A total of 17,187 GC patients in the Surveillance, Epidemiology, and End Results (SEER) database were included. On the basis of a training set of 7,660 GC patients, we built the tumor-node ratio-metastasis (TNrM) staging system, which was then externally validated with a validation set of 9,527 GC patients. Results: For the training set, the C-index value of the TNrM staging system was significantly higher than that of the AJCC 8th TNM staging system to predict survival for GC patients (C-index: 0.688 vs. 0.671, P < 0.001). Moreover, the C-index value of the TNrM staging system was significantly higher than that of the 8th TNM staging system to predict survival for GC patients with ≤15 eLNs (C-index: 0.682 vs. 0.673, P < 0.001), as well as for GC patients with >15 eLNs (C-index: 0.700 vs. 0.694, P < 0.001). Similar results were found in the validation set. Conclusions: The TNrM staging system predicted survival more accurately and discriminatively than the AJCC 8th TNM staging system for GC patients regardless of the number of eLNs.
- 17 September 2018
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 23 (3) , 460-467
Prognostic Value of the Number of Lymph Nodes Examined in Patients with Node-Negative Gastric Cancer
- 17 September 2018
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 23 (3) , 460-467
Prognostic Value of the Number of Lymph Nodes Examined in Patients with Node-Negative Gastric Cancer
- 23 October 2006
- Published by American Physical Society (APS) in Physical Review E
- Vol. 74 (4) , 046502
Hamiltonian analysis of transverse beam dynamics in high-brightness photoinjectors
A general Hamiltonian suitable for perturbative analysis of rapidly accelerating beams is derived from first principles. With the proper choice of coordinates, the resulting Hamiltonian has a simple and familiar form, yet is able to take into account the rapid acceleration, rf focusing, magnetic focusing, and average space-charge forces in rf photoinjectors. From the linear Hamiltonian, the beam-envelope evolution is solved and analyzed, which better illuminates the invariant-envelope solution as well as the theory of emittance compensation. The third-order nonlinear Hamiltonian is derived and analyzed to some extent. To make the analysis systematic and self-contained, alternative derivations are given for the smoothed ponderomotive rf focusing and the transfer matrix of a rf cavity.
- 23 October 2006
- Published by American Physical Society (APS) in Physical Review E
- Vol. 74 (4) , 046502
Hamiltonian analysis of transverse beam dynamics in high-brightness photoinjectors
A general Hamiltonian suitable for perturbative analysis of rapidly accelerating beams is derived from first principles. With the proper choice of coordinates, the resulting Hamiltonian has a simple and familiar form, yet is able to take into account the rapid acceleration, rf focusing, magnetic focusing, and average space-charge forces in rf photoinjectors. From the linear Hamiltonian, the beam-envelope evolution is solved and analyzed, which better illuminates the invariant-envelope solution as well as the theory of emittance compensation. The third-order nonlinear Hamiltonian is derived and analyzed to some extent. To make the analysis systematic and self-contained, alternative derivations are given for the smoothed ponderomotive rf focusing and the transfer matrix of a rf cavity.